In AD in vivo models, MPT0G211 treatment reduced the time spent by animals in finding the platform and closed arm in the Morris water maze and elevated plus maze test and reduced the amount of phosphorylated tau in the hippocampal CA1 region, which is related to learning and memory10. The gene discussed is MAPT; the disease is Alzheimer disease.